Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)

NCT01203787 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Sorafenib Standard Dosing Regimen
DRUG: Sorafenib Ramp-Up Regimen

Sponsor

University of Florida